Skip to main content
. Author manuscript; available in PMC: 2011 Jan 12.
Published in final edited form as: Blood Cells Mol Dis. 2010 Nov 26;46(1):66–72. doi: 10.1016/j.bcmd.2010.10.011

Table 5.

DXA Z-scores of children

Years following initiation of imiglucerase Baseline DXA ≤−1 (n=22 patients, 80 assessments)
Predicted DXA Z-score Lower 95% confidence interval Upper 95% confidence interval
Baseline (−1 to<0) −1.38 −1.73 −1.03
0 to<1 −1.31 −1.63 −0.98
1 to <2 −1.24 −1.54 −0.93
2 to <3 −1.14 −1.45 −0.83
3 to <4 −1.03 −1.37 −0.69
4 to <5 −0.92 −1.31 −0.54
5 to <6 −0.88 −1.29 −0.47
6 to <7 −0.73 −1.25 −0.21
7 to <8 . . .
8 to <9 −0.55 −1.26 0.16
9 to <10 . . .

DXA Z-scores of patients with 2 or more measurements from a non-linear mixed model in children (ages≥5 years to <12 years).

HHS Vulnerability Disclosure